American Lung Association

Overcoming Alpha-1: A Powerful Story of Survival, Treatment and Triumph

Bonnie shares her story of being diagnosed with Alpha-1 Antitrypsin Deficiency and learning to manage the rare disease.
Nasdaq

Beam Therapeutics Announces Positive Initial Data for BEAM-302 in the Phase 1/2 Trial in Alpha-1 Antitrypsin Deficiency (AATD), Demonstrating First Ever Clinical Genetic ...

Single Dose of BEAM-302 Led to Durable, Dose-dependent Increases in Total and Functional Alpha-1 Antitrypsin (AAT), Production of Corrected M-AAT, and Decreases in Mutant Z-AAT in Circulation Across ...
Seeking Alpha

Single infusion of CARVYKTI® (ciltacabtagene autoleucel) delivered lasting treatment-free remissions for at least five years in patients with relapsed or refractory multiple ...

CARTITUDE-4 analysis shows compelling overall survival and progression-free benefits in standard and high-risk subgroups across prior lines of treatment In a subset of 12 patients who underwent serial ...
Seeking Alpha

Terraco Gold Inks Third Royalty Acquisition At Spring Valley; Sees $1 Mln Cash Infusion

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. Terraco Gold (CVE:TEN) says it has agreed to a three-way transaction under which it will get a US$1.0 million non ...